Showing results (151-160 of 233) with videos related to

Sort By:
Pageof 24
Bone Marrow Transplantation|October 25, 2018
Peripheral blood progenitor cell collection in pediatric patients optimized by high pre-apheresis count of circulating CD34+ cells and high blood flowAxel Karow, Anna Wilhelm, Roland A Ammann, et al.
Nature Communications|February 17, 2021
LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cellsS S Höpner, Ana Raykova, R Radpour, et al.
Chemistry & Biodiversity|November 28, 2008
Synthesis, characterization, and antifungal activity of boron-containing thiosemicarbazonesJustin W Hicks, Christian B Kyle, Christopher M Vogels, et al.
Scientific Reports|January 18, 2017
Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantationM Beaume, T Köhler, G Greub, et al.
JCI Insight|November 2, 2021
Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cellsMagdalena Hinterbrandner, Viviana Rubino, Carina Stoll, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 5, 2002
Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?Norihiro Awaya, Gabriela M Baerlocher, Thomas J Manley, et al.
Dalton Transactions (Cambridge, England : 2003)|March 6, 2015
Location of Ge and extra-framework species in the zeolite ITQ-24A B Pinar, L B McCusker, C Baerlocher, et al.
Experimental Hematology|October 18, 2002
Longitudinal studies of telomere length in feline blood cells: implications for hematopoietic stem cell turnover in vivoTim H Brümmendorf, Jennifer Mak, Kathleen M Sabo, et al.
Clinical Genetics|June 29, 2017
A 37-year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key factors in beneficial treatmentZ Tümer, M Petris, S Zhu, et al.
Leukemia & Lymphoma|June 3, 2014
Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial)Andrea Schmid, Dorothea Friess, Behrouz Mansouri Taleghani, et al.
Pageof 24